Merck KGaA (MRK)

Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA and an Investment Account
Sell

€118.00

Buy

€118.55

arrow-up€0.00 (+0.00%)

Prices updated at 12 Dec 2025, 20:47 CET
| Prices minimum 15 mins delay
|
Prices in EUR
Merck KGaA is a pharmaceutical and chemical company. It offers prescription medicines, diagnostics, and products used in allergen immunotherapy, specialty chemicals, and probiotic nutritional supplements.
FTSE EuroFirst 300
arrow-down-0.53%
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.

Most recent dividend payment

2.200
Cash Dividend
28 Apr 2025
03 Feb 2025
29 Apr 2025
30 Apr 2025

Total dividend yield

Dividend history and forecast data table

YearDividend per shareDividend growth (%)
20252.2000-
20242.2000-
20232.20000.19
20221.85000.32
20211.40000.08
20201.30000.04
20191.2500-
20181.25000.04
20171.20000.14
20161.05000.05

Total dividend yield data table

Year
chevron-l-regular
chevron-r-regular
Dividend yield (%)Buyback yield (%)
20251.94-
20241.57-
20231.53-
20221.02-
20210.62-
20200.93-
20191.19-
20181.39-
20171.34-
20161.06-

Dividend per share

% of earnings paid to shareholders

Dividend per share data table

YearDividend per share
20252.2000
20242.2000
20232.2000
20221.8500
20211.4000
20201.3000
20191.2500
20181.2500
20171.2000
20161.0500

% of earnings paid to shareholders data table

YearPayout ratio (%)
202533.38
202435.54
202333.03
202223.15
202122.65
202029.95
201947.17
201827.53
201728.10
201630.79
Latest Financial Report as of 12 Dec 2025
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.